Hormone therapy in postmenopausal women and risk of endometrial hyperplasia-Reference-Cited by-同舟云学术

Hormone therapy in postmenopausal women and risk of endometrial hyperplasia

Published:2009-04-15 Issue: Volume: Page:
ISSN:
Container-title:Cochrane Database of Systematic Reviews
language:
Short-container-title:

Author:

Furness Susan,Roberts Helen,Marjoribanks Jane,Lethaby Anne,Hickey Martha,Farquhar Cindy

Publisher

John Wiley & Sons, Ltd

Link

https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD000402.pub3/epdf/full

Reference180 articles.

1. Comparison of two continuous combined estrogen progestogen regimens in postmenopausal women: A randomised trial;AinMelk;Fertility & Sterility,1996

2. Acceptability and patterns of endometrial bleeding in estradiol-based HRT regimens: A comparative study of cyclical sequential combinations of trimegestone or norethisterone acetate;Al-Azzawi;Climacteric,2001

3. Long-term safety of drospirinone-estradiol for hormone therapy: a randomised, double-blind, multicenter trial;Archer;Menopause,2005

4. A comparison of the effects of continuous combined regimens of 1mg 17B-estradiol and trimegestone with continuous combined estradiol and norethisterone acetate upon the bleeding profile and safety in postmenopausal women for up to 2 years;Bouchard,2002

5. Bleeding profile and endometrial safety of continuous combined regimens 1 mg 17beta-estradiol/trimegestone versus 1 or 2 mg 17beta-estradiol/norethisterone acetate in postmenopausal women;Bouchard;Gynecological Endocrinology,2005

Cited by 62 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Outdoor air pollution exposure and uterine cancer incidence in the Sister Study;JNCI: Journal of the National Cancer Institute;2024-02-12

2. Recent advances in the management of postmenopausal women with non-atypical endometrial hyperplasia;Climacteric;2023-08-14

3. Profile of endometrial cancer patient at Sanglah Hospital, Denpasar, Bali-Indonesia;Open Access Macedonian Journal of Medical Sciences;2023-03-24

4. Combined Hormonal Replacement Therapy and The Risk of Endometrial Cancer in Postmenopausal Women: A Meta-analysis;Indian Journal of Gynecologic Oncology;2022-09-24

5. HE4 is a Beneficial Biomarker in Endometrial Adenocarcinoma;Current Women s Health Reviews;2022-05